Five year risk assessment and treatment patterns in patients with chronic thromboembolic pulmonary hypertension-Reference-Cited by-同舟云学术

Five year risk assessment and treatment patterns in patients with chronic thromboembolic pulmonary hypertension

Published:2022-07-04 Issue:5 Volume:9 Page:3264-3274
ISSN:2055-5822
Container-title:ESC Heart Failure
language:en
Short-container-title:ESC Heart Failure

Author:

Kjellström Barbro¹²^ORCID,Bouzina Habib³,Björklund Erik⁴,Beaudet Amélie⁵,Edwards Susan C.⁵,Hesselstrand Roger⁶^ORCID,Jansson Kjell⁷^ORCID,Nisell Magnus⁸,Rådegran Göran³⁹^ORCID,Sandqvist Anna¹⁰,Wåhlander Håkan¹¹^ORCID,Hjalmarsson Clara¹²^ORCID,Söderberg Stefan¹³

Affiliation:

1. Lund University, Department of Clinical Sciences Lund Clinical Physiology and Skåne University Hospital Lund Sweden

2. Cardiology Unit, Department of Medicine Karolinska Institutet Stockholm Sweden

3. Department of Clinical Sciences Lund, Cardiology Lund University Lund Sweden

4. Department of Cardiology University Hospital Uppsala Sweden

5. Actelion Pharmaceuticals Allschwil Switzerland

6. Department of Clinical Sciences Lund, Section for Rheumatology Lund University and Skåne university hospital Lund Sweden

7. Department of Cardiology and Department of Clinical Physiology Institution of Medicine and Health Science Linköping University Linköping Sweden

8. Lung Unit, Department of Medicine Karolinska Institutet and Karolinska University Hospital Stockholm Sweden

9. The Haemodynamic Lab, The Section for Heart Failure and Valvular Disease, VO. Heart and Lung Medicine Skåne University Hospital Lund Sweden

10. Janssen Cilag AB Solna Sweden

11. Pediatric Heart Center, The Queen Silvia Children's Hospital, Sahlgrenska University Hospital, and Department of Pediatrics, Institute for Clinical Sciences, Sahlgrenska Academy University of Gothenburg Gothenburg Sweden

12. Department of Cardiology, Sahlgrenska Academy University of Gothenburg and Sahlgrenska University Hospital Gothenburg Sweden

13. Department of Public Health and Clinical Medicine, Medicine Unit Umeå University Umeå Sweden

Funder

Actelion Pharmaceuticals

Sveriges Kommuner och Landsting

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ehf2.14033

Reference24 articles.

1. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

2. Residual pulmonary hypertension after pulmonary endarterectomy: A meta-analysis

3. Chronic thromboembolic pulmonary hypertension

4. ERS statement on chronic thromboembolic pulmonary hypertension

5. Revisiting a Distinct Entity in Pulmonary Vascular Disease: Chronic Thromboembolic Pulmonary Hypertension (CTEPH)